Hot Life Science Investor Mandate 3: VC Looking for Innovative Small Molecule Therapeutics

19 Jun

A Venture Capital firm based in the western United States has raised two funds is looking to make venture-stage minority equity investments. The firm is willing to both lead and co-invest in rounds and considers opportunities around the globe.

The firm is looking to invest in therapeutic development, and is primarily interested in small molecule therapeutics.  The firm may also consider investing in durable medical equipment (including hospital hardware), but in general does not invest in medical devices.  The firm only invests in novel technologies and is not interested in generics or reformulations; the firm is, however, interested in highly complex, targeted drug delivery technologies.  The firm is open to investing in any indication area, and is particularly interested in opportunities in virology and infectious diseases; oncology (particularly immuno-oncology), and cardio/metabolic diseases.  The firm invests in companies at the preclinical or early clinical stages of development.  The firm’s primary criteria is scientific novelty and does not invest in ‘me-too’ or ‘me-better’ opportunities.

The firm is a highly activist investor and prefers to manage the development process after an investment is made.  The firm therefore prefers to partner with virtual biotech companies in order to harness the firm’s relationships with CROs.  The firm prefers to invest in rounds in which a lead investor is already in place.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: